GX 301Alternative Names: Telomerase peptide cancer vaccine - Genovax
Latest Information Update: 25 Sep 2015
At a glance
- Originator Genovax
- Developer Genovax; Mediolanum
- Class Cancer vaccines; Peptide vaccines; Peptides; Vaccines
- Mechanism of Action CD4-positive T lymphocyte stimulants; CD8 positive T lymphocyte stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase II Prostate cancer
- Discontinued Renal cancer